1 / 9

Featured Article :

Featured Article :. Gut Microbiota Metabolites of Dietary Lignans and Risk of Type 2 Diabetes: A Prospective Investigation in Two Cohorts of U.S. Women. Qi Sun, Nicole M. Wedick, An Pan, Mary K. Townsend, Aedin Cassidy, Adrian A. Franke, Eric B. Rimm, Frank B. Hu, and Rob M. van Dam.

ivory
Download Presentation

Featured Article :

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Featured Article: Gut Microbiota Metabolites of Dietary Lignans and Risk of Type 2 Diabetes: A Prospective Investigation in Two Cohorts of U.S. Women Qi Sun, Nicole M. Wedick, An Pan, Mary K. Townsend, Aedin Cassidy, Adrian A. Franke, Eric B. Rimm, Frank B. Hu, and Rob M. van Dam Diabetes Care Volume 37: 1287-1295 May, 2014

  2. STUDY OBJECTIVE • To examine urinary levels of enterolactone and enterodiol in relation to type 2 diabetes (T2D) risk Sun Q. et al. Diabetes Care 2014;37:1287-1295

  3. STUDY DESIGN AND METHODS • Urinary concentrations of lignan metabolites were assayed by liquid chromatography-mass spectrometry among 1,107 T2D and 1,107 control subjects • A nested case-control study was conducted in participants from the Nurses’ Health Study (NHS) and NHSII • Subjects were free of diabetes, cardiovascular disease, and cancer at urine sample collection in 1995–2001 • Incident self-reported T2D cases identified through 2008 were confirmed with a validated questionnaire Sun Q. et al. Diabetes Care 2014;37:1287-1295

  4. RESULTS • T2D subjects had significantly lower concentrations of both enterolactone and enterodiol than control subjects • Urinary concentrations of enterolactone were significantly associated with a lower risk of T2D • Higher urinary concentrations of enterodiol were also marginally significantly associated with lower T2D risk • When concentrations of both metabolites were combined to reflect total lignan intake, the OR was 0.70 for each SD increment of total lignan metabolites Sun Q. et al. Diabetes Care 2014;37:1287-1295

  5. Sun Q. et al. Diabetes Care 2014;37:1287-1295

  6. CONCLUSIONS • Lignan metabolites, especially enterolactone, are associated with a lower risk of T2D in U.S. women • Further studies are needed Sun Q. et al. Diabetes Care 2014;37:1287-1295

  7. Sun Q. et al. Diabetes Care 2014;37:1287-1295

  8. Sun Q. et al. Diabetes Care 2014;37:1287-1295

  9. Sun Q. et al. Diabetes Care 2014;37:1287-1295

More Related